Brief: Transcode Therapeutics Announces 1-For-33 Reverse Stock Split
25/11/2024 14:51
Nov 25 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES 1-FOR-33 REVERSE STOCK
SPLIT
* TRANSCODE THERAPEUTICS INC - EFFECTIVE DATE OF REVERSE
STOCK
SPLIT TO BE ANNOUNCED
Source text: ID:nGNX8yn3gs
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors